Mumps: A year of enhanced surveillance in Catalonia, Spain

Angela Dominguez; Manuel Oviedo; Nuria Torner; Gloria Carmona; Josep Costa; Joan Caylà; M. Rosa Sala; Irene Barrabeig; Neus Camps; Sofia Minguell; Josep Alvarez; Pere Godoy; Josep M. Jansà

doi:10.1016/j.vaccine.2009.03.022

Mumps: A year of enhanced surveillance in Catalonia, Spain

Angela Dominguez, Manuel Oviedo, Nuria Torner, Gloria Carmona, Josep Costa, Joan Caylà, M. Rosa Sala, Irene Barrabeig, Neus Camps, Sofia Minguell, Josep Alvarez, Pere Godoy, Josep M. Jansà

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in ≥15 years (p = 0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.

Original language	English (US)
Pages (from-to)	3492-3495
Number of pages	4
Journal	Vaccine
Volume	27
Issue number	25-26
DOIs	https://doi.org/10.1016/j.vaccine.2009.03.022
State	Published - May 26 2009
Externally published	Yes

Keywords

Enhanced surveillance
Laboratory confirmation
Mumps

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2009.03.022

Cite this

@article{99930d3e442641e7add054f565b9e678,

title = "Mumps: A year of enhanced surveillance in Catalonia, Spain",

abstract = "Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in ≥15 years (p = 0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.",

keywords = "Enhanced surveillance, Laboratory confirmation, Mumps",

author = "Angela Dominguez and Manuel Oviedo and Nuria Torner and Gloria Carmona and Josep Costa and Joan Cayl{\`a} and Sala, {M. Rosa} and Irene Barrabeig and Neus Camps and Sofia Minguell and Josep Alvarez and Pere Godoy and Jans{\`a}, {Josep M.}",

note = "Funding Information: This work was partially funded by CIBER Epidemiolog{\'i}a y Salud P{\'u}blica (CIBERESP), Spain. ",

year = "2009",

month = may,

day = "26",

doi = "10.1016/j.vaccine.2009.03.022",

language = "English (US)",

volume = "27",

pages = "3492--3495",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "25-26",

}

TY - JOUR

T1 - Mumps

T2 - A year of enhanced surveillance in Catalonia, Spain

AU - Dominguez, Angela

AU - Oviedo, Manuel

AU - Torner, Nuria

AU - Carmona, Gloria

AU - Costa, Josep

AU - Caylà, Joan

AU - Sala, M. Rosa

AU - Barrabeig, Irene

AU - Camps, Neus

AU - Minguell, Sofia

AU - Alvarez, Josep

AU - Godoy, Pere

AU - Jansà, Josep M.

N1 - Funding Information: This work was partially funded by CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

PY - 2009/5/26

Y1 - 2009/5/26

N2 - Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in ≥15 years (p = 0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.

AB - Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in ≥15 years (p = 0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.

KW - Enhanced surveillance

KW - Laboratory confirmation

KW - Mumps

UR - http://www.scopus.com/inward/record.url?scp=67349257170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349257170&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.03.022

DO - 10.1016/j.vaccine.2009.03.022

M3 - Article

C2 - 19460603

AN - SCOPUS:67349257170

SN - 0264-410X

VL - 27

SP - 3492

EP - 3495

JO - Vaccine

JF - Vaccine

IS - 25-26

ER -

Mumps: A year of enhanced surveillance in Catalonia, Spain

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this